New Neonatal Study Adds to Body of Clinical Evidence Demonstrating Masimo SET ® Pulse Oximetry’s Unique Ability to Improve Care NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) provides ...

Masimo’s revolutionary SET® pulse oximetry has been shown in more than 100 independent and objective studies to outperform other pulse oximetry technologies – even before the revisions that achieved ...

Pulse oximetry is a widely used monitoring method for measuring blood oxygen levels and pulse rate. In newborn babies, pulse oximetry can help clinicians conduct screening tests for lung or heart ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that its Founder, Chairman, and CEO, Joe Kiani, has been honored by the Ibero-American Society of Neonatology (SIBEN) at its 17 ...

Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on ...

For decades, standard clinical practice has called for examining the cardiovascular system as part of the routine newborn examination. Despite this practice, however, one in three infants with a ...

SIBEN, founded in 2004, is dedicated to improving newborn care throughout Latin America—where 15 babies die every hour, with 60% of those who die before their first birthday dying during the first 28 ...

Resistance to CCHD screening has also been observed among clinicians in the United States. In a 2009 survey of 363 pediatric cardiologists, 42% reported that current practice is inadequate for ...